IMMUNEONCO-B (01541) subscribed to a wealth management product with an amount of 87.5 million Hong Kong dollars.
Yi Ming Angco-B (01541) announced that on June 17, 2026, the company agreed to subscribe to a financial product (Vital Subscription Product) from Vital Ventures for an amount of 87.5 million Hong Kong dollars. The subscription will be funded by the internal surplus cash reserves of the Group.
IMMUNEONCO-B (01541) announced that on June 17, 2026, the company agreed to subscribe for a financial product (Vital Subscription Product) from Vital Ventures in the amount of HK $87.5 million (subscription matter). The subscription matter will be funded by the group's internal surplus cash reserves.
Related Articles
US Stock Market Move | "On completion of exceeding $1.6 billion in funding, SharonAI Holdings (SHAZ.US) surged over 12% to expand the AI factory."
A-share evening hot spot | Milestone! The 5 trillion ETF market welcomes a major event
US Stock Market Move | The news that the SEC is considering allowing the tokenization of Robinhood's stock (HOOD.US) caused it to surge over 8%.
US Stock Market Move | "On completion of exceeding $1.6 billion in funding, SharonAI Holdings (SHAZ.US) surged over 12% to expand the AI factory."
A-share evening hot spot | Milestone! The 5 trillion ETF market welcomes a major event
US Stock Market Move | The news that the SEC is considering allowing the tokenization of Robinhood's stock (HOOD.US) caused it to surge over 8%.
RECOMMEND
